tci Medicare Compliance & Reimbursement - 2005 Issue 42

HOSPITALS: October OPPS Updates Change C9255 Reporting Rules

'Pass-through' status granted to pair of C codes.This year's hospital outpatient prospective payment system changes will have their biggest impact on a facility's claims for drugs and biologicals.Effective Oct. 1, 2005, the Centers for Medicare and Medicaid Services granted "pass-through" status to C9225 (Injection, fluocinolone acetonide intravitreal implant, per 0.59 mg) and C9226 (Injection, ziconotide for intrathecal infusion, per 5 mcg), the agency announced in a September Medlearn Matters article. Other changes in the OPPS update include:• The pass-through status effective date for code J8501 (Aprepitant, oral, 5 mg) is April 4, 2005, instead of...

To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.


Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.

  • Current newsletters added each month
  • Fully searchable archives - over 4200 articles
  • ALL years/issues back to 2003 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles
Access to this feature is available in the following products:
  • tci Medicare Compliance & Reimbursement +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.